Perspectives on Vaccine – 2021

With the massive vaccine roll-out currently underway there are still many unanswered questions about these new products. Week after week there are discussions in the homeopathic and natural health care communities as we attempt to dissect the information and educate our clients in real time. Presented here is a summary of the various vaccines being discussed for distribution in the United States and when appropriate, some information regarding the manufacturer. Currently there are approximately 120 different vaccines in development globally.

None of the vaccines being offered to United States citizens resemble anything that has been distributed previously in the human population. Biotech Primer, an online science education site, explains vaccines in the following way: “The basics of immunization have been around over a century — use a disease-causing microbe, or just a part, against itself. However, the latest step in the evolution of vaccines takes a different tack, delving more deeply into the building blocks of life—DNA or RNA.”

“Instead of immunizing someone with a whole pathogen or fragment, a DNA vaccine injects only a small bit of a virus’s genetic code. Drug companies nestle the code in plasmids — small, circular DNA molecules within a pathogen. The “visiting” DNA prompts the host to produce the target viral protein and consequent immune response within their own cells, but without an infection. RNA vaccines consist of a single strand of RNA that encodes the instructions for making a viral protein, typically encased in a lipid nanoparticle.”1

Both the mRNA and DNA type of vaccines are new technology made with genetic code that mimics the spiked protein of the corona virus. This differs from previous vaccines which were made from a live or attenuated virus, making manufacturing much more cost effective. The mRNA goes directly into the cell producing the proteins that elicit the immune response. In DNA vaccines, the genetic information is transmitted to the mRNA in the cell where it is translated making for an additional cellular step for the results to be effective. These vaccines also need an electrical impulse to push the information into the cell. Once the spike protein is replicated by the cells the body mounts an immune response.

Both the Pfizer and Moderna vaccines rely on technology has never been injected in to human beings and certainly not on the scale we are now experiencing. Signifying the competitive nature of the endeavor and the potential profits at stake, Pfizer originally announced their vaccine as being 90% effective but revised that number to 95% after Moderna published a 94.5% efficacy.

Development of DNA vaccines were initiated around 30 years ago but as of today there are none approved outside of the veterinary field. Most are still in Phase I testing. Various DNA vaccines are now being tested are for cancer, HIV, and other bacterial or viral infections with over 160 active human trials in the United States alone. One serious point of contention is the quantity of synthetic DNA that must be injected into people to increase their immune response to any given pathogen. The term is immunogenicity and it refers to the ability to to induce a response. This is at the heart of whether or not a vaccine is effective and its inference can be either positive or negative.2

The PREP act (Public Readiness and Emergency Preparedness) was activated in March of 2020 and by April, its first amendment appeared giving manufacturers complete immunity from prosecution for any damage their vaccines may cause:

”…the liability immunity applies to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of medical countermeasures described in a Declaration.  The only statutory exception to this immunity is for actions or failures to act that constitute willful misconduct. 

The PREP Act also authorizes a United States Treasury fund that compensates eligible individuals for serious physical injuries or deaths directly caused by administration or use of a countermeasure covered by the Declaration.”3

Here are a few facts about the different companies manufacturing vaccines, their business practices and history.

CEO’s of both Pfizer and Moderna are on public record for selling massive amounts of their company stock holdings recently. Pfizer has a history of deception and in 2009 was ordered to pay 2.3 billion dollars for illegal marketing of several drugs, including an antibiotic and antipsychotics, the second largest drug settlement in the history of the United States.4 But as the New York Times pointed out, that amounted to less than 3 weeks of sales income for the drug giant. “The whole culture of Pfizer is driven by sales, and if you didn’t sell drugs illegally, you were not seen as a team player,” said John Kopchinski, a former Pfizer sales rep.5

“Pfizer’s COVID-19 vaccine development and manufacturing costs have been entirely self-funded, with billions of dollars already invested at risk. The company will continue bearing all the costs of development and manufacturing in an effort to help find a solution to this pandemic as fast as possible,” the company said in a Nov. 16, 2020 press release. In reality, the agreement signed with the US government in July 2020 guaranteed the company, along with their partner BioNTech, 1.95 billion dollars for the first 100 million doses. Now they are on track to earn 15 billion dollars in 2021 for Covid vaccines.

Similarly, Johnson & Johnson was ordered to pay 2.2 billion in 2013 for off-label promotion of drugs and kick-backs to physicians.

Johnson & Johnson is a virus-vectored double-stranded DNA in a human adenovirus. It enters the cell nucleus where it is unknown if it can permanently alter the recipients’ DNA. Also of concern is the possibility of chronic low-grade infection from the prolonged production of the spike protein.

Animal trials were completely abandoned in the vaccine development even though their 1993 SARS vaccine was shown to induce severe liver disease in vaccinated ferrets. Johnson & Johnson’s Covid-19 vaccine only entered Phase 3 trials in late December of 2020 but is being fast-tracked for emergency use at the time of this article.

AstroZeneca is a virus-vectored mRNA which was based on a vaccine previously developed for MERS, but was never deployed. A live adenovirus enters the cell and the viral RNA encodes for the COVID viral spike protein. Is there a potential here for new, chronic disease, liver or another key organ? Will fragments of the viral mRNA activate immune mechanisms such that they can’t “turn off?”

The Pfizer vaccine was tested on 20,000 people with another 20,000 receiving a placebo. The Moderna vaccine was tested on 30,000 people. It wasn’t stated how many were placebo and how many actually received the substance but one can gather about 15,000 in each group. The stated demographic was 18 and older but with no further details given.

Allergic reactions, including anaphylactic shock, have been documented in some receiving the vaccine, presumedly from polyethylene glycol(PEG), the lipid nanoparticle coating used to encapsulate the mRNA. Up to 72% of people have some antibodies against PEG. The exposure to PEG’s has been attributed to cosmetics and other pharmaceuticals. Up to 7% of people may be at risk for anaphylactic shock.6 A single case of apparent transverse myelitis, an inflammation of the spinal cord, temporarily halted both the trials of AstroZeneca and Johnson & Johnson. This symptom has also been documented in actual cases of Covid-19.

Paul Offit, a medical doctor on the FDA Advisory Panel, in an interview published December 3, 2020 in live JAMA webinar said, “The vaccine data so far are the tip of the iceberg. We still have to look at the base to see if anything is cracking and whether the tip is true. That being said, 20,000 people receiving a vaccine isn’t the same as 20 million. We will only find out the rare adverse events after approval of the vaccines.”7

He also stated that the vaccines offered “100% efficacy against severe disease,” an astonishing claim given the lack of information provided.

More from the JAMA interview:

Dr. Bauchner (editor-in-chief of Journal of American Medicine Association): The Pfizer and Moderna vaccines are mRNA; all the others you mention are more traditional, with the virus manipulated in some way, inactivated or attenuated. Does the fact that these first two vaccines are mRNA make you more or less concerned?

Dr. Offit: More concerned. We have no commercial experience with them. The vaccines are naked pieces of mRNA encapsulated in a complex lipid delivery system that enables the cell to take it up. If you injected the mRNA straight, ribonucleases (enzymes that dismantle RNA) would dissolve it. Once in the cell, the mRNA begins self-reproducing. It’s now making the coronavirus spike protein, which, for the most part, gets inserted into the cell membrane and to a lesser extent into the circulation.

In a New York Times article published January 29, 2021, Dr Offit said, “People who take the Johnson & Johnson vaccine should be able to safely receive a Pfizer-BioNTech or Moderna vaccine later if a booster shot is needed.”

But later in the article Dr. William Schaffner, an infectious disease expert at Vanderbilt University, warned that there was no data on the effects of receiving different types of vaccines. “We haven’t studied this,” he said. This is just a single example of the conflicting information being directed to the public, many of whom will be negatively impacted by the lack of evidential research on this unprecedented gene therapy.8

Many are concerned about the possibility of a “health passport” as proof of immunization but there is also belief the adverse long-term effects of the vaccine will prevent this. A recently published article seem to hint at both “recent negative test results” and “immunization proof” as possible requirements for this potential travel screen.9

The fundamental truth is that vaccination does not preclude anyone from contracting or spreading Covid-19; the only promise being if infected, manifesting a weaker form of the virus that would not require hospitalization. There is no evidence that the vaccine will prevent “long-haulers” syndrome, which can present even among those who did not experience a serious case of Covid-19. There are also many questions regarding pregnant women and the effect on transmission to the fetus. How will an infant’s immune system be affected by exposure to prenatal vaccination?

With the emergence of new strains there is no consensus on how effective the current vaccines will be. How long do the vaccines last and how often might boosters need to be administered, and at what intervals? How would repeated doses affect the immune system? Does the vaccine address asymptomatic infection? How does it impact viral shedding and transmission? Can herd immunity actually be reached with mass vaccination? How many people would have to be vaccinated for that to occur? What about worldwide? What is the impact if the virus is reintroduced by other animal species? How does the vaccine effect people with high co-morbidities and other chronic disease for Covid? Are there long-term adverse effects and how are those being cataloged as roll-out is accelerated? How will lower income people and minorities, their neighborhoods and nations be supported – both in terms of receiving the vaccine and also support for long-term adverse effects? Will the vaccine effect one’s ability to combat other infectious diseases? These and many other questions remain unanswered.

Dr. Will Taylor has said, “My concern has more to do with the unreasonable expectations placed on vaccination as a public health measure, and the naive, over simplistic “safe and effective” declaration of conventional practice. We need to take an “evidence-based” approach; Science can answer our questions; Dogma (including dogma disguised as “scientism”) cannot.” 

He continued, “People appear eager to embrace that a vaccinated society will be able to return to normal but the “vaccine” does not prevent transmission of the virus. Widespread vaccination is already stimulating a less compliant population. What would be more effective is a serious approach to transmission mitigation which would have greater impact than widespread application of a highly effective vaccine.“

Information provided in this article was collected from independent research as well as presentations by Dr. Will Taylor, MD, a medical doctor, researcher, homeopath, and homeopathic educator from Portland, Oregon and Kim Elia, CEO of WholeHeathNow, an educational site for homeopaths and students of homeopathy.

1. –

2. –

3. –

4 –


6. –

7. –

8. –

9. –